Autolus Therapeutics (AUTL) Technical (Analysis) Reports Autolus Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Autolus Therapeutics (AUTL)
Technical Analysis Report for NASDAQ stock AUTL Autolus Therapeutics. Dated: 21 Mar 2025 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock AUTL Autolus Therapeutics then click here. or read Experts views on Autolus Therapeutics or Forecast & share price targets of Autolus Therapeutics
Autolus Therapeutics Opened at 1.73 and Closed at: 1.70, which is 1.18% of previous session's close. It moved within a range of 1.56 and 1.75
The session was a Bearish session with an average volume of 1642900, which is -166.31% of previous session's volumes.
- Even though the stock has shown an up move, but the mid term trend of the stock remains negative and in a downtrend.
- Even though the stock has shown an up move, but the long term trend of the stock remains negative and in a downtrend.
A Golden cross was found 6 days back on short term averages
Support for tomorrow is 1.54 and resistance for tomorrow is 1.73
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 1.59, 1.48 resistance for tomorrow's hourly charts is 1.78, 1.86
10 Day SMA for Autolus Therapeutics (AUTL) is 1.86 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Autolus Therapeutics (AUTL) is 1.86 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Autolus Therapeutics (AUTL) is 2.02 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 2.51 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Autolus Therapeutics is 3.26 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Autolus Therapeutics is at 1.86 and 200 DMA is at 3.26, while 50 DMA and 100 DMA are at 2.02 and 2.51 respectively
Autolus Therapeutics (AUTL) moving average of 20 SMA is at 1.86 and 20 EMA is at 1.88
Date | Closing Price | 20 SMA | 20 EMA |
21 Fri Mar | 1.70 | 1.86 | 1.88 |
20 Thu Mar | 1.68 | 1.88 | 1.9 |
19 Wed Mar | 1.94 | 1.89 | 1.92 |
18 Tue Mar | 1.79 | 1.89 | 1.92 |
17 Mon Mar | 1.82 | 1.9 | 1.93 |
14 Fri Mar | 1.87 | 1.91 | 1.94 |
Autolus Therapeutics (AUTL) moving average of 50 SMA is at 2.02 and 50 EMA is at 2.07
Date | Closing Price | 50 SMA | 50 EMA |
21 Fri Mar | 1.70 | 2.02 | 2.07 |
20 Thu Mar | 1.68 | 2.03 | 2.08 |
19 Wed Mar | 1.94 | 2.05 | 2.1 |
18 Tue Mar | 1.79 | 2.06 | 2.11 |
17 Mon Mar | 1.82 | 2.07 | 2.12 |
14 Fri Mar | 1.87 | 2.08 | 2.13 |
Autolus Therapeutics (AUTL) moving average of 100 SMA is at 2.51 and 100 EMA is at 2.43
Date | Closing Price | 100 SMA | 100 EMA |
21 Fri Mar | 1.70 | 2.51 | 2.43 |
20 Thu Mar | 1.68 | 2.54 | 2.44 |
19 Wed Mar | 1.94 | 2.57 | 2.46 |
18 Tue Mar | 1.79 | 2.6 | 2.47 |
17 Mon Mar | 1.82 | 2.63 | 2.48 |
14 Fri Mar | 1.87 | 2.65 | 2.49 |
Autolus Therapeutics (AUTL) moving average of 200 SMA is at 3.26 and 200 EMA is at 3.13
Date | Closing Price | 200 SMA | 200 EMA |
21 Fri Mar | 1.70 | 3.26 | 3.13 |
20 Thu Mar | 1.68 | 3.27 | 3.14 |
19 Wed Mar | 1.94 | 3.29 | 3.15 |
18 Tue Mar | 1.79 | 3.3 | 3.16 |
17 Mon Mar | 1.82 | 3.31 | 3.17 |
14 Fri Mar | 1.87 | 3.32 | 3.18 |
Veru Inc has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Veru Inc, about 0.8% more returns!
Autolus Therapeutics has performed better than Veracyte Inc in short term. Holding Autolus Therapeutics could be a better choice for now!
Utah Medical has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Utah Medical, about 4.11% more returns!
Autolus Therapeutics has performed better than United Therapeutics in short term. Holding Autolus Therapeutics could be a better choice for now!
Urogen Pharma has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Urogen Pharma, about 34.11% more returns!
Novocure has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Novocure, about 0.58% more returns!
Novavax Inc has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Novavax Inc, about 12.13% more returns!
Neurometrix Inc has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Neurometrix Inc, about 12.54% more returns!
Natera Inc has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Natera Inc, about 5.01% more returns!
Autolus Therapeutics has performed better than Intellia Therapeutics in short term. Holding Autolus Therapeutics could be a better choice for now!
National Research has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in National Research, about 2.25% more returns!
Autolus Therapeutics has performed better than Neogen Corporation in short term. Holding Autolus Therapeutics could be a better choice for now!
Autolus Therapeutics has performed better than Neogenomics Inc in short term. Holding Autolus Therapeutics could be a better choice for now!
Neurocrine Biosciences has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Neurocrine Biosciences, about 3.53% more returns!
Cytokinetics Incorporated has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Cytokinetics Incorporated, about 3.94% more returns!
Biotelemetry Inc has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Biotelemetry Inc, about 6.63% more returns!
Autolus Therapeutics has performed better than Atricure Inc in short term. Holding Autolus Therapeutics could be a better choice for now!
Ascendis Pharma has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Ascendis Pharma, about 19.45% more returns!
Autolus Therapeutics Technical analysis of indicators
Price action analysis of Autolus Therapeutics (AUTL) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Autolus Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Autolus Therapeutics in short term and the sell signal is strong.
Autolus Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a SELL signal for Autolus Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Autolus Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.81 and Autolus Therapeutics AUTL stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Autolus Therapeutics AUTL stock. Volume based technical analysis of Autolus Therapeutics AUTL stock is negative.
Autolus Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock AUTL Autolus Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And AUTL Experts View which covers a lot of information including buying and selling signals
AUTL future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Autolus Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Autolus Therapeutics (AUTL) Technical (Analysis) Reports Autolus Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance